Printer Friendly

Encompass Health to Acquire Assets of Alacare Home Health/Hospice.

M2 EQUITYBITES-April 3, 2019-Encompass Health to Acquire Assets of Alacare Home Health/Hospice


3 April 2019 - Dallas, US-based healthcare services provider Encompass Health Corp. (NYSE: EHC) has agreed to purchase substantially all of the assets of Alabama, US-based Alacare Home Health and Hospice, the company said.

Terms of the transaction were not disclosed. The transaction is expected to close in 2Q19. Encompass Health will fund the purchase with cash on hand and borrowings under its revolving credit facility.

The Alacare acquisition will expand Encompass Health's home health and hospice services to new markets and complement existing inpatient rehabilitation services in Alabama.

Post-closing, it will be among the top 10 largest hospice providers in the country based on Medicare reimbursements.

Alacare Home Health and Hospice operates 23 home health locations and 23 hospice locations in Alabama and generated revenues of approximately USD 117m in 2018.

Encompass Health offers integrated healthcare services through both facility based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

With a national footprint that includes 130 hospitals, 220 home health locations, and 58 hospice locations in 36 states and Puerto Rico, the company is committed to delivering high-quality, cost-effective, integrated care across the healthcare continuum.

((Comments on this story may be sent to

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Geographic Code:1U6AL
Date:Apr 3, 2019
Previous Article:Evolution Research Group Acquires Finger Lakes Clinical Research.
Next Article:Czech Drug Manufacturer Zentiva Acquires Creo Pharmaceuticals.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters